Everybody has been talking about insulin prices in the U.S. throughout the last few years. The cost of insulin has caused families and people living with diabetes to ration their insulin supplies and cost some their lives due to this rationing. Only after massive public outcry and pressure from lawmakers, the three manufacturers of insulin announced that they will have a $35 monthly cap for people with private health insurance in the U.S. There still is not a “generic” insulin, but what we do have are biosimilars. What are biosimilar insulins? Read more.